Form 483

Porter Instrument Division Parker Hannifin Corp Form 483, 2013-11-07

FDA issued a Form 483 to Porter Instrument Division Parker Hannifin Corp on 2013-11-07 with 7 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health7 observations

Porter Instrument Division Parker Hannifin Corp · Hatfield, United States · Issued November 7, 2013

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

7 Nov 2013
21 CFR 820.25(b)

Training records

Cited by Michael J Nerz, Meena Bansal Gupta

7 Nov 2013
21 CFR 820.30(e)

Design review - Lack of or inadequate procedures

Cited by Michael J Nerz, Meena Bansal Gupta

7 Nov 2013
21 CFR 820.30(f)

Design verification - output does not meet input requirement

Cited by Michael J Nerz, Meena Bansal Gupta

7 Nov 2013
21 CFR 820.30(g)

Design validation - documentation

Cited by Michael J Nerz, Meena Bansal Gupta

7 Nov 2013
21 CFR 820.30(i)

Design changes - Lack of or Inadequate Procedures

Cited by Michael J Nerz, Meena Bansal Gupta

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.25(b)Cited across public-safe Form 483 observations1x
21 CFR 820.30(e)Cited across public-safe Form 483 observations1x
21 CFR 820.30(f)Cited across public-safe Form 483 observations1x
21 CFR 820.30(g)Cited across public-safe Form 483 observations1x
21 CFR 820.30(i)Cited across public-safe Form 483 observations1x
21 CFR 820.40Cited across public-safe Form 483 observations1x
21 CFR 820.70(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 7 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere